R&D News | pharmaphorum

News

GSK-partnered Medicago starts trials of plant-based COVID-19...

Medicago has started dosing healthy volunteers in the first human trial of its candidate vaccine for COVID-19, a few days after partnering with GlaxoSmithKline on the project.<

News

Merck & Co's CEO has doubts over fast COVID-19 vaccine devel...

Merck & Co’s CEO Kenneth Frazier has warned that the many COVID-19 vaccines under development are not guaranteed to work, adding that it may be too optimistic to expect one to be approv

News

Closeup of X-ray photography of human brain

Biogen and Eisai trial drug in asymptomatic Alzheimer's dise...

Biogen and Eisai have begun a new phase 3 study testing an Alzheimer’s antibody drug aimed at patients without symptoms but with elevated levels of amyloid in their brains, the protein aggr

News

UK firms plan early-warning detector for COVID-19 in wastewa...

Sewage monitoring is being trialled as a way to spot new outbreaks of coronavirus, and three UK companies have now joined forces to try to develop a probe for this purpose.

News

FDA to fast track development of two COVID-19 vaccines from ...

Two of Pfizer and BioNTech’s potential COVID-19 vaccines have been granted Fast Track status by the FDA, a process designed to hasten their development and review.

News

Imperial's coronavirus vaccine could be available in early 2...

Lockdown is easing across the UK but life is far from the pre-coronavirus “normal” in the absence of a vaccine that has been proven to be safe and effective.

GSK-partnered Medicago starts trials of plant-based COVID-19...

Merck & Co's CEO has doubts over fast COVID-19 vaccine devel...

Biogen and Eisai trial drug in asymptomatic Alzheimer's dise...

UK firms plan early-warning detector for COVID-19 in wastewa...

FDA to fast track development of two COVID-19 vaccines from ...

Imperial's coronavirus vaccine could be available in early 2...

Hengrui gets world-first okay for platelet drug hetrombopag

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks